Changes in and current status of obstetrician-gynecologists' knowledge, attitudes, and practice regarding immunization

Obstetrical and Gynecological Survey

Volumn 64, Issue 12, 2009, Pages 823-829

  Leddy, Meaghan A ^a   Anderson, Britta L ^a   Power, Michael L ^b   Gall, Stanley ^c   Gonik, Bernard ^d   Schulkin, Jay ^a  

^a AMERICAN UNIVERSITY   (United States)

^b University of Louisville School of Medicine   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CONTINUING EDUCATION; DRUG COST; DRUG INDICATION; DRUG SAFETY; GYNECOLOGY; HEALTH CARE COST; HEALTH SURVEY; HUMAN; IMMUNIZATION; INFECTION PREVENTION; MEDICAL EDUCATION; MEDICAL SPECIALIST; OBSTETRIC CARE; OBSTETRICIAN; PHYSICIAN ATTITUDE; PRENATAL SCREENING; REIMBURSEMENT; REVIEW; TREND STUDY; WOMEN'S HEALTH;

ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; FEMALE; GYNECOLOGY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MICHIGAN; OBSTETRICS; PAPILLOMAVIRUS VACCINES; PHYSICIAN'S PRACTICE PATTERNS; PREGNANCY; VACCINATION; YOUNG ADULT;

EID: 73449138747     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1097/OGX.0b013e3181c4bbb7     Document Type: Review

References (18)

1. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report 48: Achievements in Public Health 1900-1999, Impact of Vaccines Universally Recommended for Children. Atlanta, GA: CDC, 2006:243-248.
2. Anderson RN. Deaths: leading causes for 1999. Natl Vital Stat Rep 2001;49:1-87.
3. Gonik B, Jones T, Contreras D, et al. The obstetrician-gynecologist's role in vaccine-preventable diseases and immunization. Obstet Gynecol 2000;96:81-84.
4. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report 56: Quadrivalent Human Papilloma-virus Vaccine: Recommendations of the Advisory Committee on Immunization Practices. Atlanta, GA: CDC, 2006.
5. Ho GYF, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423.
6. Moscicki AB, Shiboski S, Broering J, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998; 132:277-284.
7. Kjaer SK, van den Brule AJC, Paull G, et al. Type specific persistence of high risk human papillomavirus as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study. BMJ 2002;325:572.
8. Walboomers JM, Jacobs MV, Manos MM, et al. Human pap-illomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.
9. Zimmerman RK. HPV vaccine and its recommendations, 2007. J Fam Pract 2007;52:S1.
10. FUTURE I. Study Group. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007;356:1928.
11. FUTURE II. Study Group. Prophylactic efficacy of a quadrivalent human papillomavirus (HPV) vaccine in women with viro-logical evidence of HPV infection. J Infect Dis 2007;196:1438.
12. American College of Obstetricians and Gynecologists. Human papillomavirus vaccination [ACOG Committee Opinion 2006 No. 344]. Obstet Gynecol 2006;108:699-705.
13. Leddy MA, Anderson BA, Gall S, et al. Obstetrician-gynecologists and the HPV vaccine: practice patterns, beliefs, and knowledge. J Pediatr Adolesc Gynecol 2009;22:239-246.
14. Power M, Leddy M, Anderson B, et al. Obstetrician-gynecologists' practices and perceived knowledge regarding immunization. Am J Prev Med 2009;37:231-234.
15. Leddy MA, Gonik B, Gall SA, et al. Changes in immunization practices, knowledge and beliefs of Michigan obstetrician-gynecologists since 2000 Michigan. J Publ Health 2009;3: 20-32.
16. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report 57: Recommended Adult Immunization Schedule\-United States, 2009. Atlanta, GA: CDC, 2008.
17. Villa LL, Costa RLR, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-278.
18. Schrag SJ, Fiore AE, Gonik B, et al. Vaccination and perinatal infection prevention practices among obstetrician-gynecologists. Obstet Gynecol 2003;101:704-710.